Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;71(11):2438-2446.
doi: 10.2337/db22-0168.

Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)

Affiliations

Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)

Jinrui Cui et al. Diabetes. .

Abstract

Gut microbiome studies have documented depletion of butyrate-producing taxa in type 2 diabetes. We analyzed associations between butyrate-producing taxa and detailed measures of insulin homeostasis, whose dysfunction underlies diabetes in 224 non-Hispanic Whites and 129 African Americans, all of whom completed an oral glucose tolerance test. Stool microbiome was assessed by whole-metagenome shotgun sequencing with taxonomic profiling. We examined associations among 36 butyrate-producing taxa (n = 7 genera and 29 species) and insulin sensitivity, insulin secretion, disposition index, insulin clearance, and prevalence of dysglycemia (prediabetes plus diabetes, 46% of cohort), adjusting for age, sex, BMI, and race. The genus Coprococcus was associated with higher insulin sensitivity (β = 0.14; P = 0.002) and disposition index (β = 0.12; P = 0.012) and a lower rate of dysglycemia (odds ratio [OR] 0.91; 95% CI 0.85-0.97; P = 0.0025). In contrast, Flavonifractor was associated with lower insulin sensitivity (β = -0.13; P = 0.004) and disposition index (β = -0.11; P = 0.04) and higher prevalence of dysglycemia (OR 1.22; 95% CI 1.08-1.38; P = 0.0013). Species-level analyses found 10 bacteria associated with beneficial directions of effects and two bacteria with adverse associations on insulin homeostasis and dysglycemia. Although most butyrate producers analyzed appear to be metabolically beneficial, this is not the case for all such bacteria, suggesting that microbiome-directed therapeutic measures to prevent or treat diabetes should be targeted to specific butyrate-producing taxa rather than all butyrate producers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlations among abundance levels of 12 species associated with insulin homeostasis traits or dysglycemia. Correlation coefficients are displayed, with shades of red representing positive values and shades of blue representing negative values. The two clusters of species are outlined with squares. *P < 0.05 and >0.01; **P < 0.01 and ≥0.0001; ***P < 0.0001.
Figure 2
Figure 2
Network of species associated with beneficial effects on insulin homeostasis and dysglycemia. Each line connecting two species indicates a significant correlation in abundance (P < 0.05). Coprococcus comes (in bold) had the greatest number of connections to other species.

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention . National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2020. Atlanta, U.S. Department of Health and Human Services, 2020
    1. Wood AC, Jensen ET, Bertoni AG, et al. . Defining the relative role of insulin clearance in early dysglycemia in relation to insulin sensitivity and insulin secretion: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Metabolites 2021;11:420. - PMC - PubMed
    1. Shah MH, Piaggi P, Looker HC, Paddock E, Krakoff J, Chang DC. Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans. Diabetologia 2021;64:914–922 - PubMed
    1. Gurung M, Li Z, You H, et al. . Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 2020;51:102590. - PMC - PubMed
    1. Jensen ET, Bertoni AG, Crago OL, et al. . Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes Obes Metab 2020;22:1976–1984 - PMC - PubMed

Publication types